Patent · US Active

Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux

US10292942B2 · kind B2 · utility

1Cited by

8References

25Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Michael Horstmann · Neuwied, DE
Mohammad Sameti · Bonn, DE
Tobias Jung · Fürstenfeldbruck, DE

Key dates

Filing date	May 30, 2007
Grant date	May 21, 2019
Priority date	—
Expiry date	May 30, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/7092
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a transdermal therapeutic system, preferably a transdermal patch, having an active ingredient-containing matrix formed substantially of a water-insoluble base material, such as rubber and synthetic polymers, into which is incorporated water-soluble and/or water-swellable inclusion bodies, e.g. inclusion bodies formed from polyvinyl alcohol or polyethylene glycol, that further include micronized or nanoscale active ingredient particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.